Biosino Bio-Technology and Science Incorporation
Research Biosino Bio-Technology and Science Incorporation (8247.HK) on Bullrun: market cap HKD 452.93M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker8247.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyHKD
- Market capHKD 452.93M
- Financial periodFY2025
- RevenueCNY 184.29M
- Revenue growth-29.9%
- Net income-CNY 51.14M
- Free cash flow-CNY 32.61M
- Gross margin38.5%
Valuation Snapshot
latest market cap is HKD 452.93M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 184.29M | -CNY 51.14M | -CNY 32.61M | 38.5% | n/a | CNY 43.52M | CNY 162.91M | CNY 120.18M |
| FY2024 | CNY 263.07M | -CNY 42.53M | CNY 8.53M | 41.2% | -0.29 | CNY 68.21M | CNY 153.85M | CNY 167.81M |
| FY2023 | CNY 289.07M | -CNY 11.65M | -CNY 23.14M | 44.1% | -0.08 | CNY 63.41M | CNY 151.45M | CNY 210.39M |
| FY2022 | CNY 373.07M | CNY 8.11M | CNY 28.06M | 39.2% | 0.06 | CNY 77.35M | CNY 151.69M | CNY 205.85M |
| FY2021 | n/a | n/a | n/a | n/a | -0.01 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 452.93M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Biosino Bio-Technology and Science Incorporation
Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Biosino Bio-Technology and Science Incorporation's market cap?
Biosino Bio-Technology and Science Incorporation's market capitalization is HKD 452.93M.
What does Biosino Bio-Technology and Science Incorporation do?
Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation Guangdong has a strategic cooperation agreement with Xiaoshou Medical Technology Co., Ltd.